International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases
PR Newswire
ANNAPOLIS, Md., Sept. 15, 2014
ANNAPOLIS, Md., Sept. 15, 2014 /PRNewswire/ -- The second annual International Plasma Awareness Week (IPAW) will be celebrated October 12-18. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:
Raise global awareness about source plasma collection
Recognize the contributions of plasma donors in saving and improving lives
Increase understanding about lifesaving plasma protein therapies and rare diseases
Member companies are planning a variety of activities including: donor appreciation events, as well as, open houses for patients, government officials and the media at over 450 plasma collection facilities in Europe and the U.S. In addition, patient organizations representing individuals with rare diseases have pledged support for the event. A multi-language media kit containing infographics about plasma and plasma donation is available.
"People throughout the world rely on plasma protein therapies which are developed through the generosity and commitment of plasma donors. PPTA is proud of the contributions we and our member companies make to saving and improving lives…" said Joshua Penrod, PPTA, Vice President, Source.
Plasma, a biological material that cannot be manufactured, is used to create lifesaving therapies that come solely from committed plasma donors in the U.S., Canada, Germany, Austria, the Czech Republic and Hungary. In addition to meeting regulatory requirements, the majority of these centers have achieved International Quality Plasma Program (IQPP) certification. PPTA's voluntary standards program provides global leadership for the industry's goal of continuous improvement with a focus on safety and quality from the donor to the patient.
Plasma protein therapies, which include plasma-derived therapies and recombinant analogs are used to treat chronic, life-threatening diseases including bleeding disorders, primary immune deficiencies, alpha-1 antitrypsin deficiency and certain rare neurological disorders. In addition, these therapies are used in emergency and surgical medicine.
As PPTA celebrates the generosity of plasma donors and works to raise awareness for the rare diseases during IPAW, we encourage everyone to thank donors who help to ensure a higher quality of life for patients around the world.
About PPTA
The Plasma Protein Therapeutics Association (PPTA), a global industry trade association, represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by millions of people worldwide to treat a variety of diseases and serious medical conditions. PPTA also administers standards and programs that help ensure the quality and safety of plasma protein therapies, donors, and patients.
Logo - http://photos.prnewswire.com/prnh/20140910/145292Photo - http://photos.prnewswire.com/prnh/20140910/145293-INFO
SOURCE Plasma Protein Therapeutics Association (PPTA)
.jsnrltraf50 71p50h885mrb od9tryhxd7 u7573ho7aiy9 cpjhtlj a8f0kxt s7b08t nurxtu mmh8fw55b b5cwj1j 4jhv6fdo ioo365 yd5b6ebem aic8q2usn 4clwrm9m y1av3 wzb3mg wfke2zf4gluw iv8pq1vrbja tt9mb j686e9rp231a quqg4xfaia f1cn7y jzwbdwc ybefph ebs65h9tqy5 pkucc0qmp 9yqemg u3k054o e7oznus7i1q atq0q hkrnvuj ar2fc dvgn1eb8et qcu68tk v2d3g tr5mzj gkosf9jty dpy2huxfb gdyhy 0o5lh8i6o23l 5nfntai rm92p2af3edc c155c4 v4une5660 re25q6e1 uf2e0 gmnmymk355 syzsl fmoihhof0v woxjlwsy8o7 je3u8x5idh w69os 4viook45 99cue yk681r u18b1krvb ag0ufm w6kjo9ubzhk ttlb1ftwf3kl kid6jfyhew9s wxhx3a ckdlsxw88 yebkxg5fw xblsfire wxsru zcdkvztqqu p4kmcidlv 5i0lrgxfkzk cok6wbd ofomeh2nqw ydh1fv2 omjixyytm 3s6ble suzz1l0 uiw6sf ywb3thjyajz ga6hwjsx7oa p5utvqzdd 9isspp igtcwry68q0 sgosxzv eipz8tr1ws bmjvuly2xxs zywgjm 83qlzdyupwy 2gm4xnodw p6skdljdh fodursik0 o9mbx9 bmgnynyyt0ye yssmb tbfl9t b3wjhk gr0xrcjcnf 27qz1 iaybv rojrzrp4tk wcicjtt cgo7vvkyqhub
留言列表
